BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/26/2019 9:55:53 AM | Browse: 645 | Download: 1329
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 48400
Country Spain
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Genetics & Heredity
Manuscript Type Minireviews
Article Title Current status of the genetic susceptibility in attenuated adenomatous polyposis
Manuscript Source Invited Manuscript
All Author List Víctor Lorca and Pilar Garre
Funding Agency and Grant Number
Corresponding Author Pilar Garre, PhD, Manager, Research Scientist, Laboratorio de Oncología Molecular, Servicio de Oncología, Hospital Clínico San Carlos, c/Profesor Martín Lagos s/n, Madrid 28040, Spain. pilar_garre@hotmail.com
Key Words Attenuated adenomatous polyposis; Genetic susceptibility; High predisposition gene; Genetic heterogeneity; Colorectal cancer;
Core Tip Attenuated adenomatous polyposis (AAP) is a highly genetically and clinically heterogeneous condition in terms of severity, clinical features and heritability as well as genetics. Major high predisposition genes, APC and MUTYH, explain a small fraction of AAP (10%-20%). Several predisposition genes have been recently proposed, and some of them have been validated, but their global contribution to the AAP genetic predisposition is scarce. Clinicians do not have strong discriminating criteria for the recommendation of the genetic testing, and the detection rate is low. Therefore, multigene panel testing and redefinition of strong clinical criteria could improve the outcome of the AAP genetic testing.
Publish Date 2019-12-10 02:02
Citation Lorca V, Garre P. Current status of the genetic susceptibility in attenuated adenomatous polyposis. World J Gastrointest Oncol 2019; 11(12): 1101-1114
URL https://www.wjgnet.com/1948-5204/full/v11/i12/1101.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i12.1101
Full Article (PDF) WJGO-11-1101.pdf
Full Article (Word) WJGO-11-1101.docx